RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+63.95%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$4.18B
AUM Growth
+$4.18B
(+40%)
Cap. Flow
+$288M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
48.69%
Holding
89
New
15
Increased
28
Reduced
14
Closed
24
Top Buys
| 1 |
Biogen
BIIB
|
$136M |
| 2 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$106M |
| 3 |
Aprea Therapeutics
APRE
|
$104M |
| 4 |
Boston Scientific
BSX
|
$73.8M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$63.9M |
Top Sells
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$155M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$139M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$114M |
| 4 |
CELG
Celgene Corp
CELG
|
$55.9M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
$49.6M |
Sector Composition
| 1 | Healthcare | 98.47% |
| 2 | Industrials | 0.33% |
| 3 | Technology | 0% |
| 4 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCEL
51
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $17.6M | 0.42% |
1,136,806
-2,300
| -0.2% | -$35.6K |
|
52
Stereotaxis
STXS
$246M
| $16.8M | 0.4% |
3,169,308
-115,692
| -4% | -$612K |
|
|
GTHX
53
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $16.2M | 0.39% |
613,734
+222,800
| +57% | +$5.89M |
|
54
CryoPort
CYRX
$426M
| $13.9M | 0.33% |
+842,363
| New | +$13.9M |
|
55
Adaptive Biotechnologies
ADPT
$1.96B
| $12.7M | 0.3% |
425,700
+1,700
| +0.4% | +$50.9K |
|
|
VAPO
56
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $11.7M | 0.28% |
959,539
| – | – |
|
|
CBIO
57
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $7.11M | 0.17% |
1,343,845
-653,802
| -33% | -$3.46M |
|
58
BioNTech
BNTX
$24.1B
| $5.88M | 0.14% |
+173,500
| New | +$5.88M |
|
|
CBAY
59
DELISTED
Cymabay Therapeutics
CBAY
| $5.52M | 0.13% |
2,813,565
-302,300
| -10% | -$593K |
|
60
Gossamer Bio
GOSS
$587M
| $4.07M | 0.1% |
260,300
-200
| -0.1% | -$3.13K |
|
|
SYRS
61
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.47M | 0.04% |
212,291
-3,676,461
| -95% | -$25.4M |
|
62
Ovid Therapeutics
OVID
$94.6M
| $506K | 0.01% |
121,950
| – | – |
|
|
ELGX
63
DELISTED
Endologix Inc
ELGX
| $124K | ﹤0.01% |
78,755
| – | – |
|
|
CSLT
64
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $14K | ﹤0.01% |
10,229
| – | – |
|
65
AnaptysBio
ANAB
$630M
| – | – |
-612,558
| Closed | -$21.4M |
|
66
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-75,000
| Closed | -$215K |
|
67
DexCom
DXCM
$30.9B
| – | – |
-304,158
| Closed | -$45.4M |
|
68
Establishment Labs
ESTA
$1.11B
| – | – |
-10,000
| Closed | -$189K |
|
69
Inspire Medical Systems
INSP
$2.53B
| – | – |
-3,910
| Closed | -$239K |
|
70
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-187,599
| Closed | -$24M |
|
71
LivaNova
LIVN
$3.09B
| – | – |
-342,987
| Closed | -$25.3M |
|
72
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-2,740
| Closed | -$247K |
|
73
Penumbra
PEN
$10.5B
| – | – |
-297,972
| Closed | -$40.1M |
|
74
Vericel Corp
VCEL
$1.69B
| – | – |
-16,720
| Closed | -$253K |
|
75
Viking Therapeutics
VKTX
$3.02B
| – | – |
-16,260
| Closed | -$112K |
|